KYLIE HARDEN: Open Payments
NPI 1861262065 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 97 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,736 · 2025 $2,639
Food & beverage: $2,341Education: $298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $589 |
| UCB, Inc. | 12 | $487 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $443 |
| Incyte Corporation | 9 | $300 |
| Amgen Inc. | 2 | $216 |
| Janssen Biotech, Inc. | 12 | $192 |
| Regeneron Healthcare Solutions, Inc. | 3 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| Lilly USA, LLC | 2 | $35 |
| Galderma Laboratories, L.P. | 2 | $32 |
Products named: Bimzelx, RINVOQ, SKYRIZI, TREMFYA, OPZELURA, Winlevi, DUPIXENT, OTEZLA.
Industry payments across KY — which companies pay providers there.
